Continuous parathyroid hormone and estrogen administration increases vertebral cancellous bone volume and cortical width in the estrogen-deficient rat

Journal of Bone and Mineral Research

Volumn 16, Issue 7, 2001, Pages 1300-1307

  Zhou, H ^a   Shen, V ^a,b,c   Dempster, D W ^a,b   Lindsay, R ^a,b  

^a HELEN HAYES HOSPITAL   (United States)

^b Department of Orthopaedic Surgery   (United States)

^c SkeleTech Inc   (United States)

Author keywords

Estrogen; Histomorphometry; Hyperparathyroidism; Osteoporosis; Parathyroid hormone

Indexed keywords

ANABOLIC AGENT; CALCEIN; PARATHYROID HORMONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOMECHANICS; BONE DENSITY; BONE TURNOVER; CANCELLOUS BONE; CONTROLLED STUDY; CORTICAL BONE; ESTROGEN DEFICIENCY; HYPERPARATHYROIDISM; LUMBAR VERTEBRA; MORPHOMETRICS; NONHUMAN; OSMOTIC MINIPUMP; OSTEOPOROSIS; POROSITY; POSTMENOPAUSE; RAT; VERTEBRA BODY;

EID: 0034979016     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.2001.16.7.1300     Document Type: Article

References (41)

1. On the mechanism of cancellous bone preservation in postmenopausal women with mild primary hyperparathyroidism
2. The histomorphometry of bone in primary hyperparathyroidism: Preservation of cancellous bone structure
3. Primary hyperparathyroidism: Iliac crest trabecular bone volume structure, remodeling, and balance evaluated by histomorphometric methods
4. Comparison of the effects of intermittent and continuous administration of human parathyroid hormone (1-34) on rat bone
5. Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone
6. Effects of continuous infusion of parathyroid hormone and parathyroid hormone-related peptide on rat bone in vivo: Comparative study by histomorphometry
7. The effects of programmed administration of human parathyroid hormone fragment (1-34) on bone histomorphometry and serum chemistry in rats
8. Skeletal disease in primary hyperparathyroidism
9. Parathyroid hormone: The clinical experience and prospects
10. Effects of mild asymptomatic primary hyperparathyroidism on bone mass in women with and without estrogen replacement therapy
11. Bone measurements in asymptomatic primary hyperparathyroidism
12. Estrogens and progestins in the management of primary hyperparathyroidism
13. Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism. A randomized, controlled trial
14. Parathyroid hormone stimulates the bone apposition rate independently of its resorptive action: Differential effects of intermittent and continuous administration
15. Skeletal effects of parathyroid hormone infusion in ovariectomized rats with or without estrogen repletion
16. Measurements of area, perimeter, and distance: Details of data collection in bone histomorphometry
17. Bone histomorphometry: Standardization of nomenclature, symbols and units
18. Frequency distributions of tetracycline-based measurements: Implications for the interpretation of bone formation indices in the absence of double-labeled surfaces
19. Primary hyperparathyroidism: Iliac crest cortical thickness, structure, and remodeling evaluated by histomorphometric methods
20. Relationship between forearm and vertebral mineral density in postmenopausal women with primary hyperparathyroidism
21. Estrogen protection against bone resorbing effects of parathyroid hormone infusion
22. Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis
23. Anabolic action of parathyroid hormone on bone
24. Effects of combined and separate intermittent administration of low-dose human parathyroid hormone fragment (1-34) and 17beta-estradiol on bone histomorphometry in ovariectomized rats with established osteopenia
25. PTH: Skeletal effects in the ovariectomized rat model for postmenopausal bone loss
26. Biochemical responses to sequential human parathyroid hormone (1-38) and calcitonin in osteoporotic patients
27. Effects of long-term infusion of physiologic doses of 1-34 PTH on bone
28. Effects of two treatment regimes with synthetic human parathyroid hormone fragment on bone formation and the tissue balance of trabecular bone in greyhounds
29. Enhanced osteoblast development after continuous infusion of hPTH (1-84) in the rat
30. Loss of cancellous bone mass and connectivity in ovariectomized rats can be restored by combined treatment with parathyroid hormone and estradiol
31. Antagonizing the parathyroid calcium receptor stimulates parathyroid hormone secretion and bone formation in osteopenic rats
32. The effect of voluntary exercise on trabecular bone mass and connectivity in the femoral neck of young rats
33. Insulin-like growth factor I mediates selective anabolic effects of parathyroid hormone in bone cultures
34. Estrogen effects on insulin-like growth factor gene expression in a human osteoblastic cell line with high levels of estrogen receptor
35. Estrogen suppresses activation but enhances formation phase of osteogenic response to mechanical stimulation in rat bone
36. Osteocytic expression of mRNA for c-fos and IGF-I: An immediate early gene response to an osteogenic stimulus
37. Biologically meaningful determinants of the in vitro strength of lumbar vertebrae
38. Two- and three-dimensional structural analysis of paired biopsies from osteoporotic patients before and after treatment with parathyroid hormone
39. Withdrawal of parathyroid hormone treatment causes rapid resorption of newly formed vertebral cancellous and bone in old rats
40. Comparison of bone formation responses to parathyroid hormone (1-34), (1-31), and (2-34) in mice
41. PTH augments similar cortical bone in rats regardless of ovarian status - A histomorphometric analysis